These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6723762)

  • 1. Metabolism of amitriptyline in patients with chronic renal failure.
    Sandoz M; Vandel S; Vandel B; Bonin B; Hory B; St Hillier Y; Volmat R
    Eur J Clin Pharmacol; 1984; 26(2):227-32. PubMed ID: 6723762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotransformation of amitriptyline in alcoholic depressive patients.
    Sandoz M; Vandel S; Vandel B; Bonin B; Allers G; Volmat R
    Eur J Clin Pharmacol; 1983; 24(5):615-21. PubMed ID: 6873139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolites.
    Vandel B; Sandoz M; Vandel S; Allers G; Volmat R
    Eur J Clin Pharmacol; 1982; 22(3):239-45. PubMed ID: 7106157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nortriptyline metabolism in chronic renal failure: metabolite elimination.
    Dawling S; Lynn K; Rosser R; Braithwaite R
    Clin Pharmacol Ther; 1982 Sep; 32(3):322-9. PubMed ID: 7105623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amitriptyline and nortriptyline plasma levels, urinary 3-methoxy-4-hydroxyphenylglycol and clinical response in depressed women.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
    Neuropsychobiology; 1986; 16(2-3):97-102. PubMed ID: 3587582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
    Vandel S; Bertschy G; Jounet JM; Allers G
    Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amitriptyline metabolism in relation to antidepressive effect.
    Edelbroek PM; Zitman FG; Schreuder JN; Rooymans HG; de Wolff FA
    Clin Pharmacol Ther; 1984 Apr; 35(4):467-73. PubMed ID: 6705444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.
    Burch JE
    Psychopharmacology (Berl); 1983; 80(3):254-8. PubMed ID: 6412270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amitriptyline and nortriptyline excretion in human breast milk.
    Brixen-Rasmussen L; Halgrener J; Jørgensen A
    Psychopharmacology (Berl); 1982; 76(1):94-5. PubMed ID: 6805016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Zerbi F; Savoldi F
    Psychopharmacology (Berl); 1990; 100(3):334-8. PubMed ID: 2315430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels.
    Breyer-Pfaff U; Gaertner HJ; Kreuter F; Scharek G; Brinkschulte M; Wiatr R
    Psychopharmacology (Berl); 1982; 76(3):240-4. PubMed ID: 6808544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amitriptyline and nortriptyline response profiles in unipolar depressed patients.
    Lehmann LS; Bowden CL; Redmond FC; Stanton BC
    Psychopharmacology (Berl); 1982; 77(2):193-7. PubMed ID: 6812139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response and plasma concentrations of amitriptyline and its metabolite-nortriptyline in depressive patients.
    Miljković B; Pokrajac M; Timotijević I; Varagić V
    Eur J Drug Metab Pharmacokinet; 1996; 21(3):251-5. PubMed ID: 8980924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum concentrations of amitriptyline and its metabolites and clinical effect in depressive patients].
    Zhang X
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Aug; 25(4):196-8, 252. PubMed ID: 1478132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies between pharmacokinetic studies of amitriptyline.
    Schulz P; Dick P; Blaschke TF; Hollister L
    Clin Pharmacokinet; 1985; 10(3):257-68. PubMed ID: 3893842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amitriptyline pharmacokinetics. Lentizol and ordinary amitriptyline tablets compared in a cross-over study of steady state plasma drug levels in depressed patients.
    Burch JE; Hullin RP
    J Pharm Pharmacol; 1982 Apr; 34(4):260-1. PubMed ID: 6124602
    [No Abstract]   [Full Text] [Related]  

  • 17. Tricyclic antidepressant and metabolite levels in chronic renal failure.
    Lieberman JA; Cooper TB; Suckow RF; Steinberg H; Borenstein M; Brenner R; Kane JM
    Clin Pharmacol Ther; 1985 Mar; 37(3):301-7. PubMed ID: 3971655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients.
    Monteleone P; Fabrazzo M
    Pharmacopsychiatry; 1994 Nov; 27(6):238-41. PubMed ID: 7870745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients.
    Brunswick DJ; Amsterdam J; Schless A; Rothbart M; Sandler K; Mendels J
    J Clin Psychiatry; 1980 Oct; 41(10):337-40. PubMed ID: 7430077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
    Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
    Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.